Telemetered characteristic monitor system and method of using the same
First Claim
1. A telemetered characteristic monitor system for monitoring a characteristic of a user, the system comprising:
- a remotely located data receiving device;
a sensor for producing a first signal indicative of a characteristic of a user and a second signal indicative of the oxygen saturation level of the sensor; and
a transmitter device including;
a housing;
a sensor connector coupled to the housing and that is connectable to the sensor to receive signals from the sensor;
a processor within the housing coupled to the sensor connector to process the signals from the sensor for delivery to the remotely located data receiving device; and
a transmitter for wirelessly transmitting the processed signals to the remotely located data receiving device.
0 Assignments
0 Petitions

Accused Products

Abstract
A telemetered characteristic monitor system includes a remotely located data receiving device, a sensor for producing signal indicative of a characteristic of a user, and a transmitter device. The transmitter device includes a housing, a sensor connector, a processor, and a transmitter. The transmitter receives the signals from the sensor and wirelessly transmits the processed signals to the remotely located data receiving device. The processor coupled to the sensor processes the signals from the sensor for transmission to the remotely located data receiving device. The data receiving device may be a characteristic monitor, a data receiver that provides data to another device, an RF programmer for a medical device, a medication delivery device (such as an infusion pump), or the like.
610 Citations
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,774 B2
Filed 02/13/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 7,892,183 B2
Filed 07/03/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte Sensor | ||
Patent #
US 20110073475A1
Filed 08/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INFUSION PUMP WITH ADD-ON MODULES | ||
Patent #
US 20110040251A1
Filed 10/28/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Flexible Mounting Unit and Cover for a Medical Device | ||
Patent #
US 20110060196A1
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,778 B2
Filed 04/20/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Mounting Unit Having a Sensor and Associated Circuitry | ||
Patent #
US 20110054275A1
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
PUMP WITH THERAPY COACHING | ||
Patent #
US 20110033833A1
Filed 10/20/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,777 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
IMPLANTABLE MEDICAL DEVICE WITH TWO OR MORE TELEMETRY SYSTEMS | ||
Patent #
US 20110066211A1
Filed 11/19/2010
|
Current Assignee
Scott T. Mazar, William J. Linder, Keith Johnson, Jeffrey A Von Arx
|
Original Assignee
Scott T. Mazar, William J. Linder, Keith Johnson, Jeffrey A Von Arx
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,901,365 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
SENSOR INSERTER ASSEMBLY HAVING ROTATABLE TRIGGER | ||
Patent #
US 20110082484A1
Filed 10/07/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ADVANCED STEP THERAPY DELIVERY FOR AN AMBULATORY INFUSION PUMP AND SYSTEM | ||
Patent #
US 20110137239A1
Filed 12/04/2009
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,938,787 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and method for continuous non-invasive glucose monitoring | ||
Patent #
US 7,963,917 B2
Filed 12/05/2005
|
Current Assignee
Echo Therapeutics Incorporated
|
Original Assignee
Echo Therapeutics Incorporated
|
INSERTER DEVICE INCLUDING ROTOR SUBASSEMBLY | ||
Patent #
US 20110106126A1
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,959,582 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method, Device and System for Providing Analyte Sensor Calibration | ||
Patent #
US 20110184268A1
Filed 01/22/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,007,446 B2
Filed 10/19/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,988,644 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Automatic power control for a radio frequency transceiver of an implantable device | ||
Patent #
US 8,019,434 B2
Filed 05/05/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Sensor Inserter Having Introducer | ||
Patent #
US 20110190603A1
Filed 09/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20110190614A1
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 8,016,774 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Methods and apparatus for lancet actuation | ||
Patent #
US 7,981,056 B2
Filed 06/18/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
INTERCONNECT FOR ON-BODY ANALYTE MONITORING DEVICE | ||
Patent #
US 20110191044A1
Filed 09/30/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for variable speed lancet | ||
Patent #
US 7,976,476 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Tissue penetration device | ||
Patent #
US 7,981,055 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and method for RF wake-up of implantable medical device | ||
Patent #
US 8,024,043 B2
Filed 04/14/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20110178378A1
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties | ||
Patent #
US 7,988,645 B2
Filed 05/03/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Telemetry duty cycle management system for an implantable medical device | ||
Patent #
US 8,046,080 B2
Filed 02/26/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,066,639 B2
Filed 06/04/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device integrated into a holster for a personal area network device | ||
Patent #
US 8,029,443 B2
Filed 09/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable medical device with two or more telemetry systems | ||
Patent #
US 8,041,432 B2
Filed 11/19/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,062,231 B2
Filed 10/11/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
System and method for enabling communications with implantable medical devices | ||
Patent #
US 8,055,350 B2
Filed 01/21/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228109A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND/OR METHOD FOR GLUCOSE SENSOR CALIBRATION | ||
Patent #
US 20100162786A1
Filed 12/29/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174166A1
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device And Methods Of Use | ||
Patent #
US 20100056889A1
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228497A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174165A1
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and System for Transferring Analyte Test Data | ||
Patent #
US 20100076288A1
Filed 11/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Method and System for Transferring Analyte Test Data | ||
Patent #
US 20100121168A1
Filed 11/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
EXPERT SYSTEM FOR INSULIN PUMP THERAPY | ||
Patent #
US 20100274751A1
Filed 05/06/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100099969A1
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100179404A1
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Correction factor testing using frequent blood glucose input | ||
Patent #
US 7,734,323 B2
Filed 01/24/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Expert system for insulin pump therapy | ||
Patent #
US 7,751,907 B2
Filed 05/24/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
SYSTEMS AND METHODS TO ADDRESS AIR, LEAKS AND OCCLUSIONS IN AN INSULIN PUMP SYSTEM | ||
Patent #
US 20100262078A1
Filed 03/23/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268049A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174163A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Telemetry duty cycle management system for an implantable medical device | ||
Patent #
US 7,738,964 B2
Filed 01/04/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte Sensor Introducer and Methods of Use | ||
Patent #
US 20100249565A1
Filed 06/07/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100099968A1
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268048A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE SENSOR AND APPARATUS FOR INSERTION OF THE SENSOR | ||
Patent #
US 20100324392A1
Filed 02/01/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268047A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
FLOW REGULATING STOPCOCKS AND RELATED METHODS | ||
Patent #
US 20100065578A1
Filed 10/29/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100100078A1
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174158A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174157A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100185069A1
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100212583A1
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CORRECTION FACTOR TESTING USING FREQUENT BLOOD GLUCOSE INPUT | ||
Patent #
US 20100222765A1
Filed 03/09/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND APPARATUS FOR HOLDING AN ONLINE LIVE AUCTION TO COMBINE FEATURES OF BOTH THE INTERNET AND TRADITIONAL, REAL WORLD AUCTIONS | ||
Patent #
US 20100287066A1
Filed 07/19/2010
|
Current Assignee
eBay Inc.
|
Original Assignee
eBay Inc.
|
Implantable medical device with two or more telemetry systems | ||
Patent #
US 7,860,574 B2
Filed 12/29/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Method and System for Transferring Analyte Test Data | ||
Patent #
US 20100309001A1
Filed 08/18/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND STRUCTURE FOR SECURING A MONITORING DEVICE ELEMENT | ||
Patent #
US 20090012377A1
Filed 06/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and System for Providing Data Management in Integrated Analyte Monitoring and Infusion System | ||
Patent #
US 20090054745A1
Filed 08/07/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090036763A1
Filed 10/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090076361A1
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 20090105570A1
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090156919A1
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090163789A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INSULIN PUMP WITH CONVENIENCE FEATURES | ||
Patent #
US 20090177154A1
Filed 01/08/2008
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Method and apparatus for mounting a data transmission device in a communication system | ||
Patent #
US 20090171182A1
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090171179A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090187088A1
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090177064A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INSULIN PUMP WITH INSULIN THERAPY COACHING | ||
Patent #
US 20090177147A1
Filed 01/07/2008
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Infusion Device and Methods Therefor | ||
Patent #
US 20090171269A1
Filed 06/29/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216102A1
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090198175A1
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216101A1
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
AUTOMATIC POWER CONTROL FOR A RADIO FREQUENCY TRANSCEIVER OF AN IMPLANTABLE DEVICE | ||
Patent #
US 20090216298A1
Filed 05/05/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Sylvia Quiles, Krishna Sridharan, Scott Vanderlinde
|
Sensor Inserter Assembly | ||
Patent #
US 20090292185A1
Filed 08/07/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and Apparatus for Providing Glycemic Control | ||
Patent #
US 20090299151A1
Filed 06/01/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and Apparatus for Providing Analyte Sensor and Data Processing Device | ||
Patent #
US 20080009692A1
Filed 09/10/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 20080034323A1
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Interface for medical infusion pump | ||
Patent #
US 20080033361A1
Filed 02/05/2007
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20080033271A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 20080033749A1
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
GLUCOSE MEASURING DEVICE INTEGRATED INTO A HOLSTER FOR A PERSONAL AREA NETWORK DEVICE | ||
Patent #
US 20080060955A1
Filed 09/20/2007
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080071156A1
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20080091096A1
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
FLEXIBLE PATCH FOR FLUID DELIVERY AND MONITORING BODY ANALYTES | ||
Patent #
US 20080119707A1
Filed 10/23/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for RF transceiver duty cycling in an implantable medical device | ||
Patent #
US 20080114412A1
Filed 12/20/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 20080126969A1
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
CARBOHYDRATE RATIO TESTING USING FREQUENT BLOOD GLUCOSE INPUT | ||
Patent #
US 20080206799A1
Filed 02/27/2007
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080188731A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080214915A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR RF WAKE-UP OF IMPLANTABLE MEDICAL DEVICE | ||
Patent #
US 20080215121A1
Filed 04/14/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
BASAL RATE TESTING USING FREQUENT BLOOD GLUCOSE INPUT | ||
Patent #
US 20080228056A1
Filed 03/13/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
ANALYTE MONITORING SYSTEM AND METHODS | ||
Patent #
US 20080281179A1
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
EXPERT SYSTEM FOR INSULIN PUMP THERAPY | ||
Patent #
US 20080294294A1
Filed 05/24/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
ANALYTE MONITORING SYSTEM AND METHODS | ||
Patent #
US 20080278332A1
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080275313A1
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE MONITORING SYSTEM AND METHODS | ||
Patent #
US 20080281171A1
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INSULIN PUMP BASED EXPERT SYSTEM | ||
Patent #
US 20080300534A1
Filed 05/30/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Inserter and methods of use | ||
Patent #
US 20070027381A1
Filed 07/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Analyte sensor | ||
Patent #
US 20070027370A1
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor retention mechanism and methods of use | ||
Patent #
US 20070078321A1
Filed 09/30/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEM AND METHOD FOR CONTINUOUS NON-INVASIVE GLUCOSE MONITORING | ||
Patent #
US 20070129621A1
Filed 12/05/2005
|
Current Assignee
Echo Therapeutics Incorporated
|
Original Assignee
Sontra Medical Corporation
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070191699A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070179370A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203410A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070208247A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070244380A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249919A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249920A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020188A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036143A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036140A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Telemetry duty cycle management system for an implantable medical device | ||
Patent #
US 20060116744A1
Filed 01/04/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte sensor | ||
Patent #
US 20060155180A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 20060270923A1
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 20050182306A1
Filed 02/16/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Server for medical device | ||
Patent #
US 20050246416A1
Filed 02/22/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040167801A1
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040171921A1
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring module and insulin pump combination | ||
Patent #
US 20040254434A1
Filed 06/10/2003
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Programmable medical infusion pump displaying a banner | ||
Patent #
US 20030163789A1
Filed 02/28/2002
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,123,700 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 8,123,686 B2
Filed 03/01/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing leak detection in data monitoring and management systems | ||
Patent #
US 8,112,240 B2
Filed 04/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Display for pump | ||
Patent #
US 8,133,197 B2
Filed 05/02/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Interface for medical infusion pump | ||
Patent #
US 8,149,131 B2
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring system and methods | ||
Patent #
US 8,149,117 B2
Filed 08/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,157,748 B2
Filed 01/10/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,423 B2
Filed 12/14/2010
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Pelikan Technologies Inc.
|
Expert system for pump therapy | ||
Patent #
US 8,219,222 B2
Filed 05/06/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Insulin pump based expert system | ||
Patent #
US 8,221,345 B2
Filed 05/30/2007
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,226,891 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,229,534 B2
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,235,915 B2
Filed 12/18/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Programmable medical infusion pump displaying a banner | ||
Patent #
US 8,250,483 B2
Filed 02/28/2002
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for fluid injection | ||
Patent #
US 8,262,614 B2
Filed 06/01/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Pelikan Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,287,495 B2
Filed 10/10/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,290,560 B2
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for RF transceiver duty cycling in an implantable medical device | ||
Patent #
US 8,290,589 B2
Filed 12/20/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Correction factor testing using frequent blood glucose input | ||
Patent #
US 8,208,984 B2
Filed 03/09/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Smiths Medical ASD Inc.
|
Method of manufacturing a fluid sampling device with improved analyte detecting member configuration | ||
Patent #
US 8,296,918 B2
Filed 08/23/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,298,184 B2
Filed 10/11/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for RF wake-up of implantable medical device | ||
Patent #
US 8,326,424 B2
Filed 08/26/2011
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Method and system for providing an integrated analyte sensor insertion device and data processing unit | ||
Patent #
US 8,333,714 B2
Filed 09/10/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,337,421 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,419 B2
Filed 10/04/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,420 B2
Filed 03/24/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Programmable insulin pump | ||
Patent #
US 8,346,399 B2
Filed 12/20/2004
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,360,991 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,360,992 B2
Filed 11/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 8,362,904 B2
Filed 04/18/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,366,637 B2
Filed 12/03/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,372,016 B2
Filed 09/30/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,403,864 B2
Filed 05/01/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Flow regulating stopcocks and related methods | ||
Patent #
US 8,408,421 B2
Filed 10/29/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,414,503 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Infusion pump with add-on modules | ||
Patent #
US 8,414,523 B2
Filed 10/28/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,430,828 B2
Filed 01/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,435,190 B2
Filed 01/19/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Interface for medical infusion pump | ||
Patent #
US 8,435,206 B2
Filed 02/05/2007
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Method and system for transferring analyte test data | ||
Patent #
US 8,437,966 B2
Filed 11/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth | ||
Patent #
US 8,439,872 B2
Filed 04/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Slideable flow metering devices and related methods | ||
Patent #
US 8,448,824 B2
Filed 02/26/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,456,301 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Glucose measuring module and insulin pump combination | ||
Patent #
US 8,460,243 B2
Filed 06/10/2003
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Abbott Diabetes Care Incorporated, Deltek Inc.
|
Analyte monitoring system and methods | ||
Patent #
US 8,461,985 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,474,397 B2
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,475,373 B2
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for transferring analyte test data | ||
Patent #
US 8,483,974 B2
Filed 11/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Programmable medical infusion pump | ||
Patent #
US 8,504,179 B2
Filed 02/28/2002
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Integrated introducer and transmitter assembly and methods of use | ||
Patent #
US 8,512,243 B2
Filed 09/30/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,512,239 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatuses for implantable medical device telemetry power management | ||
Patent #
US 8,538,528 B2
Filed 01/08/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Medical device insertion | ||
Patent #
US 8,545,403 B2
Filed 12/28/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,556,829 B2
Filed 01/27/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for transferring analyte test data | ||
Patent #
US 8,560,250 B2
Filed 08/18/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Tissue penetration device | ||
Patent #
US 8,562,545 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for mounting a data transmission device in a communication system | ||
Patent #
US 8,571,624 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for a multi-use body fluid sampling device with analyte sensing | ||
Patent #
US 8,574,168 B2
Filed 03/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,579,831 B2
Filed 10/06/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 8,585,591 B2
Filed 07/10/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing glycemic control | ||
Patent #
US 8,591,410 B2
Filed 06/01/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,593,287 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,597,575 B2
Filed 07/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor introducer and methods of use | ||
Patent #
US 8,602,991 B2
Filed 06/07/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods to address air, leaks and occlusions in an insulin pump system | ||
Patent #
US 8,608,699 B2
Filed 03/23/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Insertion devices and methods | ||
Patent #
US 8,613,703 B2
Filed 05/29/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 8,636,673 B2
Filed 12/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
System and method for RF wake-up of implantable medical device | ||
Patent #
US 8,639,339 B2
Filed 11/20/2012
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and structure for securing a monitoring device element | ||
Patent #
US 8,641,618 B2
Filed 06/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sampling module device and method | ||
Patent #
US 8,641,643 B2
Filed 04/27/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 8,641,644 B2
Filed 04/23/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,647,269 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Solute concentration measurement device and related methods | ||
Patent #
US 8,650,937 B2
Filed 09/18/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Insulin pump based expert system | ||
Patent #
US 8,657,779 B2
Filed 05/07/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 8,665,091 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 8,668,656 B2
Filed 12/31/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for transferring analyte test data | ||
Patent #
US 8,682,598 B2
Filed 08/27/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,690,796 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Insulin pump with blood glucose modules | ||
Patent #
US 8,718,949 B2
Filed 05/25/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,721,545 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electric lancet actuator | ||
Patent #
US 8,721,671 B2
Filed 07/06/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing integrated analyte monitoring and infusion system therapy management | ||
Patent #
US 8,727,982 B2
Filed 06/25/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,731,630 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
On-body medical device securement | ||
Patent #
US 8,734,344 B2
Filed 05/29/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,758,323 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 8,764,657 B2
Filed 03/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 8,771,183 B2
Filed 02/16/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Body fluid sampling device with a capacitive sensor | ||
Patent #
US 8,784,335 B2
Filed 07/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,955 B2
Filed 06/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,953 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatuses for implantable medical device telemetry power management | ||
Patent #
US 8,792,983 B2
Filed 09/06/2013
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,801,611 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Pump with therapy coaching | ||
Patent #
US 8,801,657 B2
Filed 10/20/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Methods and apparatus for penetrating tissue | ||
Patent #
US 8,808,201 B2
Filed 01/15/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion pump with activity monitoring | ||
Patent #
US 8,840,582 B2
Filed 05/29/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method for penetrating tissue | ||
Patent #
US 8,845,549 B2
Filed 12/02/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,845,550 B2
Filed 12/03/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing analyte sensor insertion | ||
Patent #
US 8,852,101 B2
Filed 09/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,858,434 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 8,858,526 B2
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Method and system for providing an integrated analyte sensor insertion device and data processing unit | ||
Patent #
US 8,862,198 B2
Filed 12/17/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Advanced step therapy delivery for an ambulatory infusion pump and system | ||
Patent #
US 8,882,701 B2
Filed 12/04/2009
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,926,561 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and system for providing data management in integrated analyte monitoring and infusion system | ||
Patent #
US 8,932,216 B2
Filed 08/07/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 8,952,794 B2
Filed 03/13/2012
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Server for medical device | ||
Patent #
US 8,954,336 B2
Filed 02/22/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Interface for medical infusion pump | ||
Patent #
US 8,965,707 B2
Filed 08/03/2006
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Tissue penetration device | ||
Patent #
US 8,965,476 B2
Filed 04/18/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Two chamber pumps and related methods | ||
Patent #
US 8,986,253 B2
Filed 08/07/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,989,833 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 8,993,331 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,000,929 B2
Filed 11/22/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Expert system for insulin pump therapy | ||
Patent #
US 9,008,803 B2
Filed 06/22/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 9,034,639 B2
Filed 06/26/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 9,035,767 B2
Filed 05/30/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,039,975 B2
Filed 12/02/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,072,842 B2
Filed 07/31/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 9,089,294 B2
Filed 01/16/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,089,678 B2
Filed 05/21/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,095,290 B2
Filed 02/27/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods to address air, leaks and occlusions in an insulin pump system | ||
Patent #
US 9,119,917 B2
Filed 12/16/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Low pain penetrating member | ||
Patent #
US 9,144,401 B2
Filed 12/12/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 9,177,456 B2
Filed 06/10/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 9,186,098 B2
Filed 03/24/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,186,468 B2
Filed 01/14/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,211,377 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 9,215,992 B2
Filed 03/24/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Body fluid sampling module with a continuous compression tissue interface surface | ||
Patent #
US 9,226,699 B2
Filed 11/09/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Error detection in critical repeating data in a wireless sensor system | ||
Patent #
US 9,226,701 B2
Filed 04/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 9,248,267 B2
Filed 07/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Flexible patch for fluid delivery and monitoring body analytes | ||
Patent #
US 9,259,175 B2
Filed 10/23/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Printable hydrogel for biosensors | ||
Patent #
US 9,261,476 B2
Filed 04/01/2014
|
Current Assignee
Sanofi-Aventis SA
|
Original Assignee
Sanofi S.A.
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 9,265,453 B2
Filed 03/24/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and/or method for glucose sensor calibration | ||
Patent #
US 9,289,168 B2
Filed 12/29/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Tissue penetration device | ||
Patent #
US 9,314,194 B2
Filed 01/11/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte monitoring system and methods | ||
Patent #
US 9,314,198 B2
Filed 04/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,314,195 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,323,898 B2
Filed 11/15/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
On-body medical device securement | ||
Patent #
US 9,326,727 B2
Filed 05/15/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing analyte sensor insertion | ||
Patent #
US 9,332,933 B2
Filed 09/29/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 9,339,612 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a variable user interface | ||
Patent #
US 9,351,680 B2
Filed 10/14/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Interconnect for on-body analyte monitoring device | ||
Patent #
US 9,351,669 B2
Filed 09/30/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing analyte sensor and data processing device | ||
Patent #
US 9,398,882 B2
Filed 09/10/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and/or method for glucose sensor calibration | ||
Patent #
US 9,402,569 B2
Filed 09/21/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensor and apparatus for insertion of the sensor | ||
Patent #
US 9,402,544 B2
Filed 02/01/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor devices, connections, and methods | ||
Patent #
US 9,402,570 B2
Filed 12/11/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Tissue penetration device | ||
Patent #
US 9,427,532 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Expert system for infusion pump therapy | ||
Patent #
US 9,474,856 B2
Filed 04/13/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated introducer and transmitter assembly and methods of use | ||
Patent #
US 9,480,421 B2
Filed 08/19/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method for penetrating tissue | ||
Patent #
US 9,498,160 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Analyte sensor retention mechanism and methods of use | ||
Patent #
US 9,521,968 B2
Filed 09/30/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing glycemic control | ||
Patent #
US 9,541,556 B2
Filed 11/25/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,555,186 B2
Filed 03/15/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 9,560,993 B2
Filed 12/20/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 9,561,000 B2
Filed 12/10/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Devices, systems and methods for on-skin or on-body mounting of medical devices | ||
Patent #
US 9,572,534 B2
Filed 06/28/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,574,914 B2
Filed 03/03/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analysis apparatus, analysis method and analysis system | ||
Patent #
US 9,588,210 B2
Filed 02/01/2011
|
Current Assignee
ARKRAY Inc
|
Original Assignee
ARKRAY Inc
|
Transcutaneous analyte sensor | ||
Patent #
US 9,603,557 B2
Filed 05/13/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,625,413 B2
Filed 05/19/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor and apparatus for insertion of the sensor | ||
Patent #
US 9,636,068 B2
Filed 06/24/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,649,057 B2
Filed 05/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Temporary suspension for closed-loop medicament therapy | ||
Patent #
US 9,669,160 B2
Filed 07/30/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,669,162 B2
Filed 03/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 9,687,183 B2
Filed 03/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor devices, connections, and methods | ||
Patent #
US 9,693,713 B2
Filed 06/27/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sampling module device and method | ||
Patent #
US 9,694,144 B2
Filed 12/03/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing data management in integrated analyte monitoring and infusion system | ||
Patent #
US 9,697,332 B2
Filed 12/08/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof | ||
Patent #
US 9,721,063 B2
Filed 03/09/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,724,021 B2
Filed 12/08/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Glucose measuring device for use in personal area network | ||
Patent #
US 9,730,584 B2
Filed 02/10/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 9,740,829 B2
Filed 09/29/2014
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Systems and methods for transcutaneously implanting medical devices | ||
Patent #
US 9,743,862 B2
Filed 03/29/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interconnect for on-body analyte monitoring device | ||
Patent #
US 9,750,444 B2
Filed 04/27/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,775,553 B2
Filed 10/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Integrated introducer and transmitter assembly and methods of use | ||
Patent #
US 9,775,563 B2
Filed 09/21/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Smart messages and alerts for an infusion delivery and management system | ||
Patent #
US 9,782,076 B2
Filed 07/18/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Variable speed sensor insertion devices and methods of use | ||
Patent #
US 9,788,771 B2
Filed 10/23/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing glycemic control | ||
Patent #
US 9,795,328 B2
Filed 01/06/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,795,334 B2
Filed 07/09/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing analyte sensor insertion | ||
Patent #
US 9,795,331 B2
Filed 04/28/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,795,747 B2
Filed 06/02/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,801,545 B2
Filed 07/30/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,802,007 B2
Filed 11/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing an integrated analyte sensor insertion device and data processing unit | ||
Patent #
US 9,808,186 B2
Filed 09/26/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insulin pump based expert system | ||
Patent #
US 9,833,177 B2
Filed 02/24/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,176 B2
Filed 07/12/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Body fluid sampling device with capacitive sensor | ||
Patent #
US 9,839,386 B2
Filed 06/12/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Infusion pump with temperature monitoring | ||
Patent #
US 9,889,250 B2
Filed 06/27/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Field update of an ambulatory infusion pump system | ||
Patent #
US 9,895,491 B2
Filed 01/14/2016
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabeters Care Inc.
|
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device | ||
Patent #
US 9,913,600 B2
Filed 02/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing glycemic control | ||
Patent #
US 9,931,075 B2
Filed 11/12/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor devices, connections, and methods | ||
Patent #
US 9,931,066 B2
Filed 05/31/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,949,678 B2
Filed 02/16/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for detecting occlusions in an infusion pump | ||
Patent #
US 9,962,486 B2
Filed 11/02/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,968,302 B2
Filed 04/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems | ||
Patent #
US 9,968,306 B2
Filed 10/21/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor inserter assembly | ||
Patent #
US 9,980,670 B2
Filed 04/03/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods | ||
Patent #
US 9,980,669 B2
Filed 11/07/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor and apparatus for insertion of the sensor | ||
Patent #
US 9,993,188 B2
Filed 03/31/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 10,010,280 B2
Filed 03/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Advanced step therapy delivery for an ambulatory infusion pump and system | ||
Patent #
US 10,016,559 B2
Filed 10/28/2014
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Clinical variable determination | ||
Patent #
US 10,016,561 B2
Filed 03/15/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Introducer assembly and methods of use | ||
Patent #
US 10,028,680 B2
Filed 03/19/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Low pain penetrating member | ||
Patent #
US 10,034,628 B2
Filed 12/20/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Sanofi-Aventis Deutschland GmbH
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,039,881 B2
Filed 07/07/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump with blood glucose alert delay | ||
Patent #
US 10,052,049 B2
Filed 08/08/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Sensor insertion devices and methods of use | ||
Patent #
US 10,070,810 B2
Filed 10/10/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same | ||
Patent #
US 10,136,845 B2
Filed 03/14/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 10,178,954 B2
Filed 05/09/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated transmitter unit and sensor introducer mechanism and methods of use | ||
Patent #
US 10,194,863 B2
Filed 02/07/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and systems for early signal attenuation detection and processing | ||
Patent #
US 10,194,844 B2
Filed 03/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing integrated analyte monitoring and infusion system therapy management | ||
Patent #
US 10,206,629 B2
Filed 04/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, devices, and methods for assembling an applicator and sensor control device | ||
Patent #
US 10,213,139 B2
Filed 05/13/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor inserter having introducer | ||
Patent #
US 10,226,207 B2
Filed 09/28/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 10,255,408 B2
Filed 08/17/2017
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Systems including vial adapter for fluid transfer | ||
Patent #
US 10,258,736 B2
Filed 01/04/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 10,292,632 B2
Filed 10/15/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing analyte sensor insertion | ||
Patent #
US 10,307,091 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for providing glycemic control | ||
Patent #
US 10,327,682 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated introducer and transmitter assembly and methods of use | ||
Patent #
US 10,342,489 B2
Filed 09/25/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Correction factor testing using frequent blood glucose input | ||
Patent #
US 10,357,607 B2
Filed 12/08/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and method for integration of insulin pumps and continuous glucose monitoring | ||
Patent #
US 10,357,606 B2
Filed 03/13/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Method and system for providing an integrated analyte sensor insertion device and data processing unit | ||
Patent #
US 10,362,972 B2
Filed 10/17/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Flexible patch for fluid delivery and monitoring body analytes | ||
Patent #
US 10,363,363 B2
Filed 01/06/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 10,429,250 B2
Filed 03/26/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interface for medical infusion pump | ||
Patent #
US 10,437,963 B2
Filed 02/19/2015
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Smart messages and alerts for an infusion delivery and management system | ||
Patent #
US 10,448,834 B2
Filed 10/05/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Field update of an ambulatory infusion pump system | ||
Patent #
US 10,456,524 B2
Filed 02/19/2018
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and/or method for glucose sensor calibration | ||
Patent #
US 10,471,207 B2
Filed 02/08/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for switching between closed loop and open loop control of an ambulatory infusion pump | ||
Patent #
US 10,569,016 B2
Filed 12/29/2016
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor on body unit | ||
Patent #
US D882,432 S1
Filed 04/18/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 10,653,317 B2
Filed 01/10/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Compact medical device inserters and related systems and methods | ||
Patent #
US 10,674,944 B2
Filed 05/13/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medication safety devices and methods | ||
Patent #
US 10,682,460 B2
Filed 01/23/2014
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Display for pump | ||
Patent #
US 10,726,100 B2
Filed 01/17/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Introducer assembly and methods of use | ||
Patent #
US 10,736,547 B2
Filed 07/09/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 10,750,952 B2
Filed 03/26/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Interconnect for on-body analyte monitoring device | ||
Patent #
US 10,765,351 B2
Filed 08/10/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 10,772,547 B1
Filed 06/19/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump incorporating information from personal information manager devices | ||
Patent #
US 10,773,015 B2
Filed 07/09/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte sensor and apparatus for insertion of the sensor | ||
Patent #
US 10,786,190 B2
Filed 01/07/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for early signal attenuation detection and processing | ||
Patent #
US 10,820,842 B2
Filed 06/18/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor control unit | ||
Patent #
US D902,408 S1
Filed 03/15/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor device | ||
Patent #
US D903,877 S1
Filed 01/25/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device | ||
Patent #
US 10,856,785 B2
Filed 03/08/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion system and components thereof | ||
Patent #
US 10,857,287 B2
Filed 07/03/2019
|
Current Assignee
Trustees of Boston University, BETA Bionics Inc.
|
Original Assignee
Boston University
|
Devices, systems and methods for on-skin or on-body mounting of medical devices | ||
Patent #
US 10,874,338 B2
Filed 06/19/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 10,881,341 B1
Filed 09/23/2020
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device inserters and processes of inserting and using medical devices | ||
Patent #
US 10,881,340 B2
Filed 01/15/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medication safety devices and methods | ||
Patent #
US 10,881,784 B2
Filed 07/28/2015
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Infusion system for preventing mischanneling of multiple medicaments | ||
Patent #
US 10,881,789 B2
Filed 10/24/2014
|
Current Assignee
Trustees of Boston University
|
Original Assignee
Boston University
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,898,114 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 6,881,551 B2
Filed 01/28/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Biosensor | ||
Patent #
US 6,893,545 B2
Filed 11/25/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Device and method employing shape memory alloy | ||
Patent #
US 6,916,159 B2
Filed 10/09/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Biosensor membranes composed of polymers containing heterocyclic nitrogens | ||
Patent #
US 6,932,894 B2
Filed 05/14/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,942,518 B2
Filed 12/28/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Anti-ferromagnetically coupled granular-continuous magnetic recording media | ||
Patent #
US 20050214585A1
Filed 03/23/2004
|
Current Assignee
Seagate Technology LLC
|
Original Assignee
Seagate Technology LLC
|
Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes | ||
Patent #
US 6,676,816 B2
Filed 05/09/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Wireless medical diagnosis and monitoring equipment | ||
Patent #
US 20040015058A1
Filed 03/24/2003
|
Current Assignee
Body Science LLC
|
Original Assignee
Motorola Inc.
|
Electrochemical analyte sensors using thermostable soybean peroxidase | ||
Patent #
US 6,689,265 B2
Filed 03/23/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method and apparatus for enhancing the integrity of an implantable sensor device | ||
Patent #
US 20040064156A1
Filed 12/31/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
High reliability multlayer circuit substrates and methods for their formation | ||
Patent #
US 20040061234A1
Filed 09/26/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensors and methods for making them | ||
Patent #
US 20040074785A1
Filed 10/18/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Multilayer substrate | ||
Patent #
US 20040061232A1
Filed 12/26/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Implantable sensor method and system | ||
Patent #
US 20040064133A1
Filed 12/31/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic-Minimed
|
Hemostatic system and components for extracorporeal circuit | ||
Patent #
US 6,733,471 B1
Filed 09/15/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte detection system with software download capabilities | ||
Patent #
US 20040093167A1
Filed 11/08/2002
|
Current Assignee
OptiScan Biomedical Corporation
|
Original Assignee
Hercules Technology Growth Capital Inc.
|
Electrodes with multilayer membranes and methods of making the electrodes | ||
Patent #
US 6,746,582 B2
Filed 05/11/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Mass transport limited in vivo analyte sensor | ||
Patent #
US 20040111017A1
Filed 11/25/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,749,740 B2
Filed 12/28/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Telemetered characteristic monitor system and method of using the same | ||
Patent #
US 6,809,653 B1
Filed 12/17/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Biosensor | ||
Patent #
US 6,503,381 B1
Filed 09/18/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 6,514,718 B2
Filed 11/29/2001
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,554,798 B1
Filed 06/16/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method and system for non-vascular sensor implantation | ||
Patent #
US 20030078560A1
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,565,509 B1
Filed 09/21/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Handheld personal data assistant (PDA) with a medical device and method of using the same | ||
Patent #
US 6,558,320 B1
Filed 01/20/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electrochemical analyte sensor | ||
Patent #
US 20030088166A1
Filed 11/11/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,560,471 B1
Filed 01/02/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Blood analyte monitoring through subcutaneous measurement | ||
Patent #
US 6,579,690 B1
Filed 07/24/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 6,591,125 B1
Filed 06/27/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 6,592,745 B1
Filed 05/17/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Biological fuel cell and methods | ||
Patent #
US 20030152823A1
Filed 03/10/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith | ||
Patent #
US 6,605,201 B1
Filed 11/14/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Polymeric transition metal complexes and uses thereof | ||
Patent #
US 6,605,200 B1
Filed 11/14/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Integrated lancing and measurement device and analyte measuring methods | ||
Patent #
US 6,607,658 B1
Filed 11/15/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Reusable ceramic skin-piercing device | ||
Patent #
US 6,623,501 B2
Filed 04/05/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 20030176183A1
Filed 03/29/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,616,819 B1
Filed 11/04/1999
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method of manufacturing small volume in vitro analyte sensor | ||
Patent #
US 6,618,934 B1
Filed 06/15/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking | ||
Patent #
US 20030168338A1
Filed 09/19/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Process for producing an electrochemical biosensor | ||
Patent #
US 20030188427A1
Filed 03/31/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 20030199744A1
Filed 04/17/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Mass transport limited in vivo analyte sensor | ||
Patent #
US 6,654,625 B1
Filed 06/16/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Reusable analyte sensor site and method of using the same | ||
Patent #
US 20030220552A1
Filed 02/12/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same | ||
Patent #
US 6,671,554 B2
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System and method of communicating between an implantable medical device and a remote computer system or health care provider | ||
Patent #
US 20020082665A1
Filed 01/18/2001
|
Current Assignee
Rosellini Scientific Benelux SPRL
|
Original Assignee
Medtronic Incorporated
|
Method of applying insulation for coating implantable components and other microminiature devices | ||
Patent #
US 6,472,122 B1
Filed 09/09/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Real time self-adjusting calibration algorithm | ||
Patent #
US 20020161288A1
Filed 05/08/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electrochemical analyte sensor | ||
Patent #
US 6,484,046 B1
Filed 07/10/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,175,752 B1
Filed 04/30/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Implantable substrate sensor | ||
Patent #
US 6,259,937 B1
Filed 06/19/1998
|
Current Assignee
AFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Subcutaneous glucose electrode | ||
Patent #
US 6,329,161 B1
Filed 09/22/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Alumina insulation for coating implantable components and other microminiature devices | ||
Patent #
US 6,043,437 A
Filed 12/19/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Implantable enzyme-based monitoring systems adapted for long term use | ||
Patent #
US 6,081,736 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical sensor and integrity tests therefor | ||
Patent #
US 6,088,608 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical analyte measurement system | ||
Patent #
US 6,083,710 A
Filed 06/16/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Process for producing an electrochemical biosensor | ||
Patent #
US 6,103,033 A
Filed 03/04/1998
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Electrochemical analyte measurement system | ||
Patent #
US 6,121,009 A
Filed 07/16/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Method of using a small volume in vitro analyte sensor | ||
Patent #
US 6,120,676 A
Filed 06/04/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces | ||
Patent #
US 6,119,028 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical analyte | ||
Patent #
US 6,134,461 A
Filed 03/04/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Small volume in vitro analyte sensor | ||
Patent #
US 6,143,164 A
Filed 12/16/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Subcutaneous glucose electrode | ||
Patent #
US 6,162,611 A
Filed 01/03/2000
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
System and method for deriving relative physiologic signals | ||
Patent #
US 5,904,708 A
Filed 03/19/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Low power current to frequency converter circuit for use in implantable sensors | ||
Patent #
US 5,917,346 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical analyte sensors using thermostable peroxidase | ||
Patent #
US 5,972,199 A
Filed 02/11/1997
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Subcutaneous glucose electrode | ||
Patent #
US 5,965,380 A
Filed 01/12/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Low power rectifier circuit for implantable medical device | ||
Patent #
US 5,999,849 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Daisy chainable sensors and stimulators for implantation in living tissue | ||
Patent #
US 5,999,848 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Hermetically sealed electrical feedthrough for use with implantable electronic devices | ||
Patent #
US 5,750,926 A
Filed 08/16/1995
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Transdermal introducer assembly | ||
Patent #
US 5,779,665 A
Filed 05/08/1997
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Patient monitoring system | ||
Patent #
US 5,791,344 A
Filed 01/04/1996
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Subcutaneous glucose electrode | ||
Patent #
US 5,593,852 A
Filed 09/01/1994
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Adam Heller, Michael V. Pishko
|
Glucose sensor assembly | ||
Patent #
US 5,660,163 A
Filed 05/18/1995
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Medication infusion device with blood glucose data input | ||
Patent #
US 5,665,065 A
Filed 05/26/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Soybean peroxidase electrochemical sensor | ||
Patent #
US 5,665,222 A
Filed 10/11/1995
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Flex circuit connector | ||
Patent #
US 5,482,473 A
Filed 05/09/1994
|
Current Assignee
MINI Med Incorporated
|
Original Assignee
Minimed Inc.
|
Glucose monitoring system | ||
Patent #
US 5,497,772 A
Filed 11/19/1993
|
Current Assignee
MANN ALFRED E. FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Biosensor including chemically modified enzymes | ||
Patent #
US 5,543,326 A
Filed 03/04/1994
|
Current Assignee
Ioanis Katakis, Ling Ye, Adam Heller
|
Original Assignee
Ioanis Katakis, Ling Ye, Adam Heller
|
Closed loop infusion pump system with removable glucose sensor | ||
Patent #
US 5,569,186 A
Filed 04/25/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Transcutaneous sensor insertion set | ||
Patent #
US 5,586,553 A
Filed 02/16/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Transcutaneous sensor insertion set | ||
Patent #
US 5,390,671 A
Filed 03/15/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Method of fabricating thin film sensors | ||
Patent #
US 5,391,250 A
Filed 03/15/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Method of making a thin film electrical component | ||
Patent #
US 5,403,700 A
Filed 01/22/1992
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Techniques to improve the performance of electrochemical sensors | ||
Patent #
US 5,411,647 A
Filed 01/25/1994
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Acrylic copolymer membranes for biosensors | ||
Patent #
US 5,284,140 A
Filed 02/11/1992
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Apparatus and method for implantation of sensors | ||
Patent #
US 5,299,571 A
Filed 01/22/1993
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Hydrophilic polyurethane membranes for electrochemical glucose sensors | ||
Patent #
US 5,322,063 A
Filed 10/04/1991
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Electrode and method for the detection of hydrogen peroxide | ||
Patent #
US 5,320,725 A
Filed 05/08/1992
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Interferant eliminating biosensor | ||
Patent #
US 5,356,786 A
Filed 12/02/1993
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Data transfer system for an infusion pump | ||
Patent #
US 5,376,070 A
Filed 09/29/1992
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Proctective case for a medication infusion pump | ||
Patent #
US 5,370,622 A
Filed 04/28/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Glucose test data acquisition and management system | ||
Patent #
US 5,371,687 A
Filed 11/20/1992
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Boehringer Mannheim Corporation
|
Enzyme electrodes | ||
Patent #
US 5,262,035 A
Filed 08/02/1989
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. HELLER AND COMPANY
|
Interferant eliminating biosensors | ||
Patent #
US 5,262,305 A
Filed 09/03/1991
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Enzyme electrodes | ||
Patent #
US 5,264,105 A
Filed 03/17/1993
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Enzyme electrodes | ||
Patent #
US 5,264,104 A
Filed 05/08/1992
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Infusion pump with dual position syringe locator | ||
Patent #
US 5,080,653 A
Filed 04/16/1990
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Medication infusion system having optical motion sensor to detect drive mechanism malfunction | ||
Patent #
US 5,097,122 A
Filed 04/16/1990
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Thin film electrical component | ||
Patent #
US 5,108,819 A
Filed 02/14/1990
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
System for monitoring and controlling blood glucose | ||
Patent #
US 5,101,814 A
Filed 08/11/1989
|
Current Assignee
CB-CARMEL BIOTECHNOLOGY LTD.
|
Original Assignee
Yoram Palti
|
Implantable glucose sensor | ||
Patent #
US 5,165,407 A
Filed 04/09/1991
|
Current Assignee
University of Kansas
|
Original Assignee
University of Kansas
|
Implantable medication infusion system | ||
Patent #
US 4,871,351 A
Filed 08/26/1987
|
Current Assignee
Vladimir Feingold
|
Original Assignee
Vladimir Feingold
|
Patient-operated glucose monitor and diabetes management system | ||
Patent #
US 4,731,726 A
Filed 05/19/1986
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
HealthWare Corporation
|
Transparent multi-oxygen sensor array and method of using same | ||
Patent #
US 4,781,798 A
Filed 05/08/1987
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Electrochemical cell sensor for continuous short-term use in tissues and blood | ||
Patent #
US 4,671,288 A
Filed 06/13/1985
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Solenoid drive apparatus for an external infusion pump | ||
Patent #
US 4,678,408 A
Filed 09/24/1985
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
External infusion pump apparatus | ||
Patent #
US 4,685,903 A
Filed 01/06/1984
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Solenoid drive apparatus for an external infusion pump | ||
Patent #
US 4,562,751 A
Filed 01/06/1984
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Plural module medication delivery system | ||
Patent #
US 4,494,950 A
Filed 01/19/1982
|
Current Assignee
Johns Hopkins University
|
Original Assignee
Johns Hopkins University
|
Mixtures of polymers for medical use | ||
Patent #
US 4,433,072 A
Filed 04/29/1983
|
Current Assignee
HOSPAL-SODIP S.A.
|
Original Assignee
HOSPAL-SODIP S.A.
|
11 Claims
-
1. A telemetered characteristic monitor system for monitoring a characteristic of a user, the system comprising:
-
a remotely located data receiving device; a sensor for producing a first signal indicative of a characteristic of a user and a second signal indicative of the oxygen saturation level of the sensor; and a transmitter device including; a housing; a sensor connector coupled to the housing and that is connectable to the sensor to receive signals from the sensor; a processor within the housing coupled to the sensor connector to process the signals from the sensor for delivery to the remotely located data receiving device; and a transmitter for wirelessly transmitting the processed signals to the remotely located data receiving device. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
1 Specification
This application is a continuation of U.S. patent application Ser. No. 10/898,589, filed on Jul. 23, 2004 and issued as U.S. Pat. No. 7,098,803 on Aug. 29, 2006, which is a continuation of U.S. patent application Ser. No. 09/465,715, filed on Dec. 17, 1999 and issued as U.S. Pat. No. 6,809,653 on Oct. 26, 2005, which is a continuation of U.S. patent application Ser. No. 09/377,472, filed on Aug. 19, 1999 and later abandoned, which claimed priority from U.S. Provisional Application Ser. No. 60/103,812, filed on Oct. 8, 1998, each of which is herein incorporated by reference.
This invention relates to telemetered subcutaneous sensor devices and, in particular embodiments, to devices and methods for wireless communication between an implantable subcutaneous sensor set at a selected insertion site within the body of a user and a remotely located characteristic monitor.
Over the years, a variety of implantable electrochemical sensors have been developed for detecting and/or quantifying specific agents or compositions in a patient'"'"'s blood. For instance, glucose sensors have been developed for use in obtaining an indication of blood glucose levels in a diabetic patient. Such readings are useful in monitoring and/or adjusting a treatment regimen which typically includes the regular administration of insulin to the patient. Thus, blood glucose readings improve medical therapies with semi-automated medication infusion pumps of the external type, as generally described in U.S. Pat. Nos. 4,562,751; 4,678,408; and 4,685,903; or automated implantable medication infusion pumps, as generally described in U.S. Pat. No. 4,573,994, which are herein incorporated by reference.
Generally, small and flexible electrochemical sensors can be used to obtain periodic readings over an extended period of time. In one form, flexible subcutaneous sensors are constructed in accordance with thin film mask techniques in which an elongated sensor includes thin film conductive elements encased between flexible insulative layers of polyimide sheets or similar material. Such thin film sensors typically include a plurality of exposed electrodes at one end for subcutaneous placement with a user'"'"'s interstitial fluid, blood, or the like, and a corresponding exposed plurality of conductive contacts at another end for convenient external electrical connection with a suitable monitoring device through a wire or cable. Typical thin film sensors are described in commonly assigned U.S. Pat. Nos. 5,390,671; 5,391,250; 5,482,473; and 5,586,553 which are incorporated by reference herein. See also U.S. Pat. No. 5,299,571.
Drawbacks to the use of implantable sensors arise from the use of a wired connection between the implantable sensor set and the monitor. The use of the wire or cable is an additional inconvenience to users that already utilize an external infusion pump that includes an infusion insertion set and tube to infuse the medication. Also, the preferred site for some sensing device may be inconvenient for connection by wire to a characteristic monitor. For implantable pumps, the wire or cable negates the very benefit of having an internal device without external wires or cables. For Type 2 diabetics, who do not necessarily need or use an infusion pump, the use of a cable is seen as an inconvenience that may inhibit use of the device. In addition, the use of a wire or cable limits a user'"'"'s ability to position the monitor, since it can be placed no further away than the ultimate length of the wire or cable. Thus, the user must normally wear the monitor, which can be problematic. For example, removal of the monitor for sleeping can be difficult, since a user would tend to become “tangled” in the wire or cable, between the sensor and the monitor, during the normal tossing and turning that occurs during sleep. Furthermore, the more connections the user must deal with (e.g., infusion pump and catheter and/or monitor with wire to sensor), the more complicated it is to use the devices, and the less likely the user will maintain compliance with the medical regimen due to perceived and actual difficulties with all of the wires and cables.
It is an object of an embodiment of the present invention to provide an improved telemetered implantable sensor set (such as a subcutaneous or percutaneous sensor) and monitor connection device, which obviates for practical purposes, the above mentioned limitations.
According to an embodiment of the invention, a telemetered characteristic monitor system includes a remotely located data receiving device, a sensor for producing signal indicative of a characteristic of a user, and a transmitter device. In preferred embodiments, the transmitter device includes a housing, a sensor connector, a processor, and a transmitter. A potentiostat within the transmitter device may be coupled to the sensor connector and applies power to the sensor. The sensor connector receives the produced signals from the sensor. The processor is coupled to the sensor connector and processes the signals from the sensor for delivery to the remotely located data receiving device. The transmitter is coupled to the processor for wirelessly transmitting the processed signals to the remotely located data receiving device. In preferred embodiments, the data receiving device is a characteristic monitor. However, in other embodiments, the data receiving device is a data receiver that provides data to another device, an RF programmer, a medication delivery device (such as an infusion pump), or the like.
In particular embodiments, the transmitter of the transmitter device transmits the processed signals by radio frequencies. In other embodiments, the sensor may be implanted in and/or through subcutaneous, dermal, sub-dermal, intra-peritoneal or peritoneal tissue, and the sensor connector of the transmitter device includes a cable that is connected to the sensor. Also, the implantable sensor can be configured for a wired connection to a characteristic monitor, and the sensor connector of the transmitter device is formed to connect to the configured implantable sensor. Still further embodiments of the transmitter device include a receiver to receive data and instructions from the characteristic monitor, or the like.
Embodiments of the transmitter device (when used with a subcutaneous or percutaneous sensor) may include a bio-compatible adhesive to secure the housing to a skin surface of the user. Preferably, the housing of the transmitter device is less than about 3.0 inches in diameter by 0.5 inches thick. In addition, the housing is resistant to fluids when immersed in a fluid, operable in a temperature range of 0° C. to 50.° C., and has an operable life of at least 3 months. If the sensor is fully implanted, the transmitter that is connected to the sensor may be secured by sutures, sewing rings, or the like.
Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, various features of embodiments of the invention.
A detailed description of embodiments of the invention will be made with reference to the accompanying drawings, wherein like numerals designate corresponding parts in the several figures.
As shown in the drawings for purposes of illustration, the invention is embodied in a telemetered characteristic monitor transmitter coupled to a sensor set, that may be implanted in and/or through subcutaneous, dermal, sub-dermal, inter-peritoneal or peritoneal tissue, that transmits data from the sensor set to the characteristic monitor for determining body characteristics. In preferred embodiments of the present invention, the sensor set and monitor are for determining glucose levels in the blood and/or body fluids of the user without the use of, or necessity of, a wire or cable connection between the transmitter and the monitor. However, it will be recognized that further embodiments of the invention may be used to determine the levels of other agents, characteristics or compositions, such as hormones, cholesterol, medication concentrations, pH, oxygen saturation, viral loads (e.g., HIV), or the like. In other embodiments, the sensor set may also include the capability to be programmed or calibrated using data received by the telemetered characteristic monitor transmitter device, or may be calibrated at the monitor device (or receiver). The telemetered characteristic monitor system is primarily adapted for use in subcutaneous human tissue. However, still further embodiments may be placed in other types of tissue, such as muscle, lymph, organ tissue, veins, arteries or the like, and used in animal tissue. Embodiments may provide sensor readings on an intermittent or continuous basis.
The telemetered characteristic monitor system 1, in accordance with a preferred embodiment of the present invention include a percutaneous sensor set 10, a telemetered characteristic monitor transmitter device 100 and a characteristic monitor 200. The percutaneous sensor set 10 utilizes an electrode-type sensor, as described in more detail below. However, in alternative embodiments, the system may use other types of sensors, such as chemical based, optical based or the like. In further alternative embodiments, the sensors may be of a type that is used on the external surface of the skin or placed below the skin layer of the user. Preferred embodiments of a surface mounted sensor would utilize interstitial fluid harvested from underneath the skin. The telemetered characteristic monitor transmitter 100 generally includes the capability to transmit data. However, in alternative embodiments, the telemetered characteristic monitor transmitter 100 may include a receiver, or the like, to facilitate two-way communication between the sensor set 10 and the characteristic monitor 200. The characteristic monitor 200 utilizes the transmitted data to determine the characteristic reading. However, in alternative embodiments, the characteristic monitor 200 may be replaced with a data receiver, storage and/or transmitting device for later processing of the transmitted data or programming of the telemetered characteristic monitor transmitter 100.
In addition, a relay or repeater 4 may be used with a telemetered characteristic monitor transmitter 100 and a characteristic monitor 200 to increase the distance that the telemetered characteristic monitor transmitter 100 can be used with the characteristic monitor 200, as shown in
Still further embodiments of the telemetered characteristic monitor transmitter 100 may have and use an input port for direct (e.g., wired) connection to a programming or data readout device and/or be used for calibration of the sensor set 10. Preferably, any port would be water proof (or water resistant) or include a water proof, or water resistant, removable cover.
The purpose of the telemetered characteristic monitor system I (see
The monitor system 1 also removes inconvenience by separating the monitor electronics into two separate devices; a telemetered characteristic monitor transmitter 100, which attaches to the implantable sensor set 10; and a characteristic monitor 200 (or other receiver), which is carried like a pager. This provides several advantages over wire connected devices. For instance, the user can more easily conceal the presence of the monitor system 1, since a wire will not be visible (or cumbersome), within clothing. Such remote communication also provides greater convenience and flexibility in the placement of the sensor. It also makes it is easier to protect the characteristic monitor 200, which can be removed from the user'"'"'s body during showers, exercise, sleep or the like. In addition, the use of multiple components (e.g., transmitter 100 and characteristic monitor 200) facilitates upgrades or replacements, since one module or the other can be modified or replaced without requiring complete replacement of the monitor system 1. Further, the use of multiple components can improve the economics of manufacturing, since some components may require replacement on a more frequent basis, sizing requirements may be different for each module, there may be different assembly environment requirements, and modifications can be made without affecting the other components.
The telemetered characteristic monitor transmitter 100 takes characteristic information, such as glucose data or the like, from the percutaneous sensor set 10 and transmits it via wireless telemetry to the characteristic monitor 200, which displays and logs the received glucose readings. Logged data can be downloaded from the characteristic monitor 200 to a personal computer, laptop, or the like, for detailed data analysis. In further embodiments, the telemetered characteristic monitor system 1 may be used in a hospital environment or the like. Still further embodiments of the present invention may include one or more buttons (on the telemetered characteristic monitor transmitter 100 or characteristic monitor 200) to record data and events for later analysis, correlation, or the like. In addition, the telemetered characteristic monitor transmitter 100 may include a transmit on/off button for compliance with safety standards and regulations to temporarily suspend transmissions. Further buttons can include a sensor on/off button to conserve power and to assist in initializing the sensor set 10. The telemetered characteristic monitor transmitter 100 and characteristic monitor 200 may also be combined with other medical devices to combine other patient data through a common data network and telemetry system.
Further embodiments of the percutaneous sensor set 10 would monitor the temperature of the sensor set 10, which can then be used to improve the calibration of the sensor. For instance, for a glucose sensor, the enzyme reaction activity may have a known temperature coefficient. The relationship between temperature and enzyme activity can be used to adjust the sensor values to more accurately reflect the actual characteristic levels. In addition to temperature measurements, the oxygen saturation level can be determined by measuring signals from the various electrodes of the sensor set 10. Once obtained, the oxygen saturation level may be used in calibration of the sensor set 10 due to changes in the oxygen saturation levels, and its effects on the chemical reactions in the sensor set 10. For instance, as the oxygen level goes lower the sensor sensitivity may be lowered. The oxygen level can be utilized in calibration of the sensor set 10 by adjusting for the changing oxygen saturation. In alternative embodiments, temperature measurements may be used in conjunction with other readings to determine the required sensor calibration.
As shown in
In preferred embodiments, the percutaneous sensor set 10 facilitates accurate placement of a flexible thin film electrochemical sensor 12 of the type used for monitoring specific blood parameters representative of a user'"'"'s condition. Preferably, the sensor 12 monitors glucose levels in the body, and may be used in conjunction with automated or semi-automated medication infusion pumps of the external or implantable type as described in U.S. Pat. No. 4,562,751; 4,678,408; 4,685,903 or 4,573,994, to control delivery of insulin to a diabetic patient.
Preferred embodiments of the flexible electrochemical sensor 12 are constructed in accordance with thin film mask techniques to include elongated thin film conductors embedded or encased between layers of a selected insulative material such as polyimide film or sheet, and membranes. The sensor electrodes 20 at a tip end of the sensing portion 18 are exposed through one of the insulative layers for direct contact with patient blood or other body fluids, when the sensing portion 18 (or active portion) of the sensor 12 is subcutaneously placed at an insertion site. The sensing portion 18 is joined to a connection portion 24 (see
As is known in the art, and illustrated schematically in
The proximal part of the sensor 12 is mounted in a mounting base 30 adapted for placement onto the skin of a user. As shown, the mounting base 30 is a pad having an underside surface coated with a suitable pressure sensitive adhesive layer 32, with a peel-off paper strip 34 normally provided to cover and protect the adhesive layer 32, until the sensor set 10 is ready for use. As shown in
The insertion needle 14 is adapted for slide-fit reception through a needle port 42 formed in the upper base layer 36 and further through the lower bore 40 in the lower base layer 38. As shown, the insertion needle 14 has a sharpened tip 44 and an open slot 46 which extends longitudinally from the tip 44 at the underside of the needle 14 to a position at least within the bore 40 in the lower base layer 36. Above the mounting base 30, the insertion needle 14 may have a full round cross-sectional shape, and may be closed off at a rear end of the needle 14. Further description of the needle 14 and the sensor set 10 are found in U.S. Pat. No. 5,586,553, entitled “TRANSCUTANEOUS SENSOR INSERTION SET” and co-pending U.S. patent application Ser. No. 08/871,831, entitled “DISPOSABLE SENSOR INSERTION ASSEMBLY,” which are herein incorporated by reference.
The cannula 16 is best shown in
As shown in
The telemetered characteristic monitor 100 (also known as Potentiostat Transmitter Device) includes a housing 106 that supports a printed circuit board 108, batteries 110, antenna 112, and the cable 102 with the connector 104. In preferred embodiments, the housing 106 is formed from an upper case 114 and a lower case 116 that are sealed with an ultrasonic weld to form a waterproof (or resistant) seal to permit cleaning by immersion (or swabbing) with water, cleaners, alcohol or the like. In preferred embodiments, the upper and lower case 114 and 116 are formed from a medical grade plastic. However, in alternative embodiments, the upper case 114 and lower case 116 may be connected together by other methods, such as snap fits, sealing rings, RTV (silicone sealant) and bonded together, or the like, or formed from other materials, such as metal, composites, ceramics, or the like. In other embodiments, the separate case can be eliminated and the assembly is simply potted in epoxy or other moldable materials that is compatible with the electronics and reasonably moisture resistant. In preferred embodiments, the housing 106 is disk or oval shaped. However, in alternative embodiments, other shapes, such as hour glass, rectangular or the like, may be used. Preferred embodiments of the housing 106 are sized in the range of 2.0 square inches by 0.35 inches thick to minimize weight, discomfort and the noticeability of the telemetered characteristic monitor transmitter 100 on the body of the user. However, larger or smaller sizes, such as 1.0 square inches and 0.25 inches thick or less, and 3.0 square inches and 0.5 inches thick or more, may be used. Also, the housing may simply be formed from potted epoxy, or other material, especially if the battery life relative to the device cost is long enough, or if the device is rechargeable.
As shown, the lower case 116 may have an underside surface coated with a suitable pressure sensitive adhesive layer 118, with a peel-off paper strip 120 normally provided to cover and protect the adhesive layer 118, until the sensor set telemetered characteristic monitor transmitter 100 is ready for use. In preferred embodiments, the adhesive layer 118 includes an anti-bacterial agent to reduce the chance of infection; however, alternative embodiments may omit the agent. In further alternative embodiments, the adhesive layer 118 may be omitted and the telemetered characteristic monitor transmitter 100 is secured to the body by other methods, such as an adhesive overdressing, straps, belts, clips or the like.
In preferred embodiments, the cable 102 and connector 104 are similar to (but not necessarily identical to) shortened versions of a cable and connector that are used to provide a standard wired connection between the sensor set 10 and the characteristic monitor 200. This allows the telemetered characteristic monitor transmitter 100 to be used with existing sensor sets 10, and avoids the necessity to re-certify the connector portion 24 of the sensor set 10 for use with a wireless connection. The cable 102 should also include a flexible strain relief portion (not shown) to minimize strain on the sensor set 10 and prevent movement of the inserted sensor 12, which can lead to discomfort or dislodging of the sensor set 10. The flexible strain relief portion is intended to minimize sensor artifacts generated by user movements that might cause the sensing area of the sensor set 10 to move relative to the body tissues in contact with the sensing area of the sensor set 10.
The printed circuit board 108 of the telemetered characteristic monitor transmitter 100 includes a sensor interface 122, processing electronics 124, timers 126, and data formatting electronics 128, as shown in
Preferably, the battery assembly will use a weld tab design to connect power to the system. For example, it can use three series silver oxide 357 battery cells 110, or the like. However, it is understood that different battery chemistries may be used, such as lithium based chemistries, alkaline batteries, nickel metalhydride, or the like, and different numbers of batteries can be used. In further embodiments, the sensor interface 122 will include circuitry and/or a mechanism for detecting connection to the sensor set 10. This would provide the capability to save power and to more quickly and efficiently start initialization of the sensor set 10. In preferred embodiments, the batteries 110 have a life in the range of 3 months to 2 years, and provide a low battery warning alarm. Alternative embodiments may provide longer or shorter battery lifetimes, or include a power port, solar cells or an inductive coil to permit recharging of rechargeable batteries in the telemetered characteristic monitor transmitter 100.
In preferred embodiments, the telemetered characteristic monitor transmitter 100 provides power, through the cable 102 and cable connector 104 to the sensor set 10. The power is used to monitor and drive the sensor set 10. The power connection is also used to speed the initialization of the sensor 12, when it is first placed under the skin. The use of an initialization process can reduce the time for sensor 12 stabilization from several hours to an hour or less. The preferred initialization procedure uses a two step process. First, a high voltage (preferably between 1.0-1.2 volts—although other voltages may be used) is applied to the sensor 12 for 1 to 2 minutes (although different time periods may be used) to allow the sensor 12 to stabilize. Then, a lower voltage (preferably between 0.5-0.6 volts—although other voltages may be used) is applied for the remainder of the initialization process (typically 58 minutes or less). Other stabilization/initialization procedures using differing currents, currents and voltages, different numbers of steps, or the like, may be used. Other embodiments may omit the initialization/stabilization process, if not required by the sensor or if timing is not a factor.
At the completion of the stabilizing process, a reading may be transmitted from the sensor set 10 and the telemetered characteristic monitor transmitter 100 to the characteristic monitor 200, and then the user will input a calibrating glucose reading into characteristic monitor 200. In alternative embodiments, a fluid containing a known value of glucose may be injected into the site around the sensor set 10, and then the reading is sent to the characteristic monitor 200 and the user inputs the known concentration value, presses a button (not shown) or otherwise instructs the monitor to calibrate using the known value. During the calibration process, the telemetered characteristic monitor transmitter 100 checks to determine if the sensor set 10 is still connected. If the sensor set 10 is no longer connected, the telemetered characteristic monitor transmitter 100 will abort the stabilization process and sound an alarm (or send a signal to the characteristic monitor 200 to sound an alarm).
Preferably, the transmissions (or telemetry) of the telemetered characteristic monitor transmitter 100 will contain at least the following information: a unique ID code that uniquely identifies each telemetered characteristic monitor transmitter 100, a sensor characteristic data signal representative of the measured characteristic value (e.g., glucose or the like) from the sensor 18 of the subcutaneous sensor set 10, a counter electrode voltage, a low battery flag, and error detection bits (such as CRC).
Preferred embodiments utilize a time-slicing transmission protocol. Use of the time slicing protocol facilitates the use of multiple signals on the same frequency bands or to the same receiver from multiple transmitters. The time-slicing may also be used to obviate the need for a receiver in the telemetered characteristic monitor transmitter 100. For instance, the use of intermittent transmission reduces the amount of power required to operate the transmitter 100 and to extend the life of the device. It also saves power in the characteristic monitor 200 by reducing the amount of time the characteristic monitor 200 must spend in the receive mode.
In preferred embodiments, when the telemetered characteristic monitor transmitter 100 is connected to the sensor set 10, it detects the connection and is activated. Next, if desired or necessary, the telemetered characteristic monitor transmitter 100 initializes the sensor 12 of the sensor set 10. After (or in some cases during) initialization, the telemetered characteristic monitor transmitter 100 sends out a message of between 100-150 ms length every 5 minutes. Although other timing intervals ranging from 1 second to 30 minutes may be used.
Preferably, the message is transmitted in a pseudo-randomly selected time window within the 128 seconds following the 5 minute interval. In preferred embodiments, the telemetered characteristic transmitter 100 utilizes its own unique ID as a random-seed to set up a table of transmission time windows that defines the order in which the telemetered characteristic monitor 100 will transmit a message following the 5 minute interval. The order is repeated after the table is set-up. Included in the message sent will be the message count number, which indicates where in the sequence of time windows the telemetered characteristic monitor transmitter is currently transmitting. The characteristic monitor 200 uses the unique ID code of the telemetered characteristic monitor transmitter 100 to set up a corresponding table in the characteristic monitor 200 and the received message count to synchronize the characteristic monitor 200 with the current position in the table being used by the telemetered characteristic monitor transmitter 100 to predict the next time window to be used. The use of pseudo-random time windows prevents multiple transmitters from continuously interfering with other transmitting devices that are temporarily, or inadvertently, synchronized with the telemetered characteristic monitor transmitter 100. The characteristic monitor 200 acquires the transmitted message, and determines the time window in which the characteristic monitor 200 must be in a receive mode to acquire the next message. The characteristic monitor 200 then places itself in the receive mode every 5 minutes (although other timing intervals from 1 second to 30 minutes may be used) to receive the next message and data from the telemetered characteristic monitor transmitter 100 at the next predicted time window. Thus, the characteristic monitor 200 needs only be in the receive mode for 1 second (i.e., 1 time window); rather than 128 seconds (128 time windows). In alternative embodiments, the characteristic monitor 200 may not use the unique ID and the message count and may remain in the receive mode during the entire period (e.g., for 128 time windows) during which a transmission is possible. In addition, other embodiments may cause the characteristic monitor 200 to enter the receive mode 1 time window ahead and stay on for 1 time window longer to maximize the likelihood of receiving the next transmission. In further alternative embodiments, the telemetered characteristic monitor transmitter 100 and/or characteristic monitor 200 may utilize other methods or numbers to determine when transmission time windows are selected. Alternative message time-slicing transmission parameters, such as message length, number of time windows, frequency of transmissions, or the like, that are larger or smaller then those describe above, may also be used. Preferred embodiments transmit the data and/or information at a data rate between 1000 Hz to 4000 Hz modulated onto a high frequency carrier wave. However, alternative embodiments may use smaller or larger transmission rates, with the rate being selected based on user environment, power requirements, interference issues, redundancy criteria, or the like.
If a transmitted message is not received by the characteristic monitor 200 after a predetermined period of time, an alarm will be sounded or provided. In addition, the characteristic monitor 200 may continue to attempt to receive the next message by entering the receive mode at the next anticipated transmission time or may expand to enter the receive mode to cover all time windows until the next message is received.
In another alternative embodiment, if there is little or no likelihood of interference from other telemetered characteristic monitor transmitter 100, such as by message length, frequency selections or the like, the telemetered characteristic monitor transmitter 100 may transmit at one time window for all cases (typically the choice of window may be randomly selected at connection of a sensor set 10 or set at the factory). This permits the characteristic monitor 200 to be in the receive mode for even shorter periods of time (i.e., approximately 200 ms to bracket the telemetered characteristic monitor transmitter 100 transmission instead of the 128 seconds (or 1 second if able to predict the next time window) needed to bracket 128 windows) to conserve power in the characteristic monitor 200. For instance, in this scenario, the characteristic monitor 200 will be in a non-receive mode for 299.8 seconds and in a receive mode for 200 ms. In particular embodiments the non-receive mode and receive mode periods will be determined by the message length and expected frequency of transmission. It is also noted that in a system where the receiver must cover a range of time windows, the receiver may lock on to a particular range of time windows to permit the receiver being in the receive mode for shorter periods of time.
The use of these transmission protocols obviates the need for a transmitter and receiver in both the telemetered characteristic monitor transmitter 100 and characteristic monitor 200, which reduces costs, simplifies the system design, reduces power consumption and the like. However, alternative embodiments may include the capability for two-way communication, if desirable. In further embodiments, the telemetered characteristic monitor transmitter 100 transmits continuously and the characteristic monitor 200 enters the receive mode when desired or required to determine a characteristic value, such as a glucose level or the like.
In preferred embodiments, the telemetered characteristic monitor transmitter 100 will have the ability to uniquely identify itself to the characteristic monitor 200. The telemetered characteristic monitor transmitter 100 will have an operating range to the characteristic monitor 200 of at least 10 feet. In alternative embodiments, larger or smaller ranges may be used, with the selection being dependent on the environment in which the telemetered characteristic monitor transmitter 100 will be used, the size and needs of the user, power requirements, and the like.
In further alternative embodiments, the telemetered characteristic monitor transmitter 100 can be combined with a sensor set 10 as a single unit. This would be particularly well adapted where batteries and the transmitter can be made cheaply enough to facilitate changing the transmitter 100 with each new sensor set 10.
As shown in
The characteristic monitor 200 also includes circuitry in the TD 204 to uniquely mate it to an identified telemetered characteristic monitor transmitter 100. In preferred embodiments, the identification number of the telemetered characteristic monitor transmitter 100 is entered manually by the user using keys located on the characteristic monitor 200. In alternative embodiments, the characteristic monitor 200 includes a “learn ID” mode. Generally, the “learn ID” mode is best suited for the home environment, since multiple telemetered characteristic monitor transmitters 100, typically encountered in a hospital setting, are less likely to cause confusion in the characteristic monitor 200 when it attempts to learn an ID code. In addition, the characteristic monitor 200 will include the ability to learn or be reprogrammed to work with a different (or replacement) telemetered characteristic monitor transmitter 100. The preferred operating distance is at least 10 feet. In alternative embodiments, larger or smaller ranges may be used, with the selection being dependent on the environment in which the telemetered characteristic monitor transmitter 100 will be used, the size and needs of the user, power requirements, and the like. Furthermore, if the characteristic monitor 200 does not receive a transmission from the identified telemetered characteristic monitor transmitter 100 after a certain period of time (e.g., one or more missed transmissions), an alarm will be sounded.
In preferred embodiments, the characteristic monitor 200 utilizes a two processor system, in which the Host 206 is the master processor and the TD 204 is a slave processor dedicated to telemetry processing. A first communication protocol between the Host 206 and the TD 204 is shown in
In alternative embodiments, the TD 204 and Host 206 may be combined together in a single semiconductor chip to obviate the need for dual processors and to reduce the space needed for the electronics. In further embodiments, the functions of the TD 204 and Host 206 may be allocated differently between one or more processors.
As shown in
Preferably, the characteristic monitor uses batteries (not shown) to provide power to the characteristic monitor. For example, a plurality of silver oxide batteries may be used. However, it is understood that different battery chemistries may be used, such as lithium based, alkaline based, nickel metalhydride, or the like, and different numbers of batteries can be used. In preferred embodiments, the batteries have a life in the range of 1 month to 2 years, and provide a low battery warning alarm. Alternative embodiments may provide longer or shorter battery lifetimes, or include a power port, solar cells or an induction coil to permit recharging of rechargeable batteries in the characteristic monitor 200. In preferred embodiments, the batteries are not replaceable to facilitate waterproofing the housing 106.
In further embodiments of the present invention, the characteristic monitor 200 may be replaced by a different device. For example, in one embodiment, the telemetered characteristic monitor transmitter 100 communicates with an RF programmer (not shown) that is also used to program and obtain data from an infusion pump or the like. The RF programmer may also be used to update and program the transmitter 100, if the transmitter 100 includes a receiver for remote programming, calibration or data receipt. The RF programmer can be used to store data obtained from the sensor 18 and then provide it to either an infusion pump, characteristic monitor, computer or the like for analysis. In further embodiments, the transmitter 100 may transmit the data to a medication delivery device, such as an infusion pump or the like, as part of a closed loop system. This would allow the medication delivery device to compare sensor results with medication delivery data and either sound alarms when appropriate or suggest corrections to the medication delivery regimen. In preferred embodiments, the transmitter 100 would include a transmitter to receive updates or requests for additional sensor data. An example of one type of RF programmer can be found in U.S. patent application Ser. No. 60/096,994 filed Aug. 18, 1998 and is entitled “INFUSION DEVICE WITH REMOTE PROGRAMMING, CARBOHYDRATE CALCULATOR AND/OR VIBRATION ALARM CAPABILITIES,” or U.S. patent application Ser. No. 09/334,858 filed Jun. 17, 1999 and is entitled “EXTERNAL INFUSION DEVICE WITH REMOTE PROGRAMMING, BOLUS ESTIMATOR AND/OR VIBRATION ALARM CAPABILITIES,” both of which are herein incorporated by reference.
In further embodiments, the telemetered characteristic monitor transmitter can include a modem, or the like, to transfer data to and from a healthcare professional. Further embodiments, can receive updated programming or instructions via a modem connection.
In use, the sensor set 10 permits quick and easy subcutaneous placement of the active sensing portion 18 at a selected site within the body of the user. More specifically, the peel-off strip 34 (see
Next, the user connects the connection portion 24 of the sensor set 10 to the cable 102 of the telemetered characteristic monitor transmitter 100, so that the sensor 12 can then be used over a prolonged period of time for taking blood chemistry or other characteristic readings, such as blood glucose readings in a diabetic patient. Preferred embodiments of the telemetered characteristic monitor transmitter 100 detect the connection of the sensor 12 to activate the telemetered characteristic monitor transmitter 100. For instance, connection of the sensor 12 may activate a switch or close a circuit to turn the telemetered characteristic monitor transmitter 100 on. The use of a connection detection provides the capability to maximize the battery and shelf life of the telemetered characteristic monitor transmitter prior to use, such as during manufacturing, test and storage. Alternative embodiments of the present invention may utilize an on/off switch (or button) on the telemetered characteristic monitor transmitter 100.
The transmitter 100 is then affixed to the user'"'"'s body with an adhesive overdressing. Alternatively, the peel-off strip 34 (see
The user then programs the characteristic monitor (or it learns) the identification of the transmitter 100 and verifies proper operation and calibration of the transmitter 100. The characteristic monitor 200 and transmitter 100 then work to transmit and receive sensor data to determine characteristic levels. Thus, once a user attaches a transmitter 100 to a sensor set 10, the sensor 12 is automatically initialized and readings are periodically transmitted, together with other information, to the characteristic monitor 200.
After a sensor set 10 has been used for a period of time, it is replaced. The user will disconnect the sensor set 10 from the cable 102 of the telemetered characteristic monitor transmitter 100. In preferred embodiments, the telemetered characteristic monitor transmitter 100 is removed and posited adjacent the new site for a new sensor set 10. In alternative embodiments, the user does not need to remove the transmitter 100. A new sensor set 10 and sensor 12 are attached to the transmitter 100 and connected to the user'"'"'s body. Monitoring then continues, as with the previous sensor 12. If the user must replace the telemetered characteristic monitor transmitter 100, the user disconnects the transmitter 100 from the sensor set 10 and the user'"'"'s body. The user then connects a new transmitter 100, and reprograms the characteristic monitor (or learns) to work with the new transmitter 100. Monitoring then continues, as with the previous sensor 12.
Additional embodiments of the present invention may include a vibrator alarm (or optional indicator such as an L.E.D.) in either or both the telemetered characteristic monitor transmitter 100 and the characteristic monitor 200 to provide a tactile (vibration) alarm to the user, such as sensor set malfunction, improper connection, low battery, missed message, bad data, transmitter interference, or the like. The use of a vibration alarm provides additional reminders to an audio alarm, which could be important with someone suffering an acute reaction, or to have non-audio alarms to preserve and conceal the presence of the telemetered characteristic monitor system 1.
While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.